Jaguar Health (JAGX) Asset Utilization Ratio (2015 - 2026)
Jaguar Health (JAGX) reported Asset Utilization Ratio of 0.78 for Q1 2026, up 254.38% year-over-year from 0.22 in Q1 2025, and up 197.69% quarter-over-quarter from 0.26 in Q4 2025.
Jaguar Health (JAGX) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 12 years of Asset Utilization Ratio data on file, last reported at 0.78 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.78, up 254.38% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.78 (up 254.38% YoY), and the FY2025 annual result was 0.25, up 11.83% from the prior year.
- Asset Utilization Ratio improved to 0.78 in Q1 2026 per JAGX's latest filing, from 0.26 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.78 in Q1 2026 and troughed at 0.06 in Q1 2022.
- A 5-year average of 0.2 and a median of 0.17 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2022 and 2026: Asset Utilization Ratio tumbled 74.93% in 2022, then soared 254.38% in 2026.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.12 in 2022, then jumped by 31.4% to 0.16 in 2023, then advanced by 28.21% to 0.21 in 2024, then advanced by 25.51% to 0.26 in 2025, then jumped by 197.69% to 0.78 in 2026.
- Business Quant data shows JAGX's Asset Utilization Ratio at 0.78 in Q1 2026, 0.26 in Q4 2025, and 0.24 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 0.55 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Jaguar Health | 1.44 Mn | -10.19 Mn | 19.11 Mn | 0.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.78 |
| Dec 31, 2025 | 0.26 |
| Sep 30, 2025 | 0.24 |
| Jun 30, 2025 | 0.24 |
| Mar 31, 2025 | 0.22 |
| Dec 31, 2024 | 0.21 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.17 |
| Mar 31, 2024 | 0.19 |
| Dec 31, 2023 | 0.16 |
| Sep 30, 2023 | 0.11 |
| Jun 30, 2023 | 0.11 |
| Mar 31, 2023 | 0.12 |
| Dec 31, 2022 | 0.12 |
| Sep 30, 2022 | 0.16 |
| Jun 30, 2022 | 0.11 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.08 |
| Sep 30, 2021 | 0.18 |
| Jun 30, 2021 | 0.20 |